Roche acquires Stratos Genomics
Topics: ROCHE STRATOS GENOMICS
The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™).
The Roche nanopore sequencer, once developed, will utilise a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.
Stratos Genomics will continue operations in Seattle, Washington, U.S.
Financial details of the agreement were not disclosed. ■